Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-781-3 | CAS number: 117527-94-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The oral LD50 value in rat is > 5000 mg/kg bw (OECD 401, GLP).
The dermal LD50 in rat is > 2000 mg/kg bw (OECD 402, GLP).
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15.07.-29.07.1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Sulzfeld, FRG
- Age at study initiation: 7 weeks
- Fasting period before study: Animals were fasted overnight prior to dosing until 15 minutes after administration of the test substance.
- Housing: polycarbonate cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5d
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-20 °C
- Humidity (%): 60-90%
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: 15 - 29 July 1988 - Route of administration:
- oral: gavage
- Vehicle:
- other: 1% aqueous methylcellulose
- Details on oral exposure:
- Amount of vehicle: 20 ml/ kg bw
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 males + 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: once daily
- Necropsy of survivors performed: yes
- Other examinations performed:
Clinical observations were performed once on the day of dosing (due to the late dosing time no further periodic observations were performed)
and once daily thereafter for 14 days (inadvertently, the observations on day 5 were missed). Any signs of toxicity were recorded along with the time of onset and duration. Individual bodyweights were measured weekly. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality occured.
- Mortality:
- No mortality occured.
- Clinical signs:
- other: No signs of toxicity were observed during the 14 day observation period.
- Gross pathology:
- Macroscopic examination of all animals at termination did not reveal any changes that there considered to have arisen as a result of treatment.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 09.08.-23.08.1988
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Sulzfeld, FRG
- Age at study initiation: 10 weeks
- Housing: polycarbonate cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5d
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19-22 °C
- Humidity (%): 60-85%
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: To: 09 - 23 August 1988 - Type of coverage:
- semiocclusive
- Vehicle:
- other: 1% aqueous methyl cellulose
- Details on dermal exposure:
- TEST SITE
The test substance was suspended in 1% aqueous methyl cellulose and spread on a surgical gauze (5x5 cm and 5x3.5 cm for males and females, respectively). This was fixed to, successively, aluminium foil and flexible bandage with drops of vaseline. This patch was then applied to the clipped area of each animal and fixed with adhesive tape.
REMOVAL OF TEST SUBSTANCE
After 24 hrs of exposure, the semi-occlusive bandage was removed and the remaining test substance was gently removed with tissues, moistened with tap water. The day of application of the test substance was considered as day 0.
TEST MATERIAL
The dose level was 2000 mg/kg bw and the dose volume was 20 ml/kg bw.
- Constant volume or concentration used: yes - Duration of exposure:
- 24 hrs
- Doses:
- 2000 mg/kg bw (males and females)
- No. of animals per sex per dose:
- 5 males + 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Clinical observations were performed on the day of dosing (approximately once every two hours) and once daily thereafter for 14 days. Any signs of toxicity were recorded along with the time of onset and duration. Individual bodyweights were measured weekly.
- Necropsy of survivors performed: yes
- Other examinations performed: In addition, observations regarding changes of the treated surface were performed following bandage removal and on days 4, 7 and 14. At the end of the study (day 14) all animals were anaesthetised by CO2/O2 inhalation, subsequently killed by CO2 and subjected to necropsy. - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality occurred.
- Mortality:
- No mortality occurred.
- Clinical signs:
- other: No signs of toxicity were oberved during the 14 day observation period (with the exception of one animal showing hypothermia at the time of bandage removal, most probably due to tight application of the bandage). Following bandage removal and until day 4
- Gross pathology:
- Macroscopic examination at necropsy of all animals at the end of the study did not reveal any changes that were considered to have arisen as a result of treatment.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Additional information
Oral route:
In an acute oral toxicity study according to OECD TG 401 and GLP (RCC NOTOX B.V. 1988), groups of fasted, young adult Wistar rats (5/sex) were given a single oral dose of the test substance in 1% methyl cellulose at 5000 mg/kg bw and consecutively observed for 14 days. No mortality occured and no signs of toxicity were observed during the 14 day observation period. Bodyweight development was not impaired.
The oral LD50 value was determined to be > 5000 mg/kg bw.
Inhalation route:
No experimental data is available on the UVCB substance itself. A reliable study is available for the organometallic UVCB part. It misses the salt formation with the branched alkylamine and is therefore only of supportive evidence. It shows that at least from the organometallic part, there is no hazard for acute inhalation toxicity at dust concentrations of up to 5 mg/m3 air.
Dermal route:
The acute dermal toxicity of the test substance at the limit dose of 2000 mg/kg bw, was studied in Wistar rats (5/sex) according to OECD TG 402 and GLP (RCC NOTOX B.V.a). There were no deaths and no systemic response to treatment in any animal throughout the study. No dermal reactions were observed in any animal during the study. Two male animals showed a temporary bodyweight decrease during the first week of observation. All other animals were considered to have achieved satisfactory bodyweight gains throughout the study. Based on these results the acute lethal dermal dose to rats of the test substance was demonstrated to be greater than 2000 mg/kg bw.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for acute oral or dermal toxicity under Directive 67/548/EEC, as amended for the 28th time in Directive 2001/59/EC.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for acute oral or dermal toxicity under Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.